Viral-Human Chimeric Transcript Predisposes Risk to Liver Cancer Development and Progression
Chi-Chiu Lau(Chinese University of Hong Kong), Nathalie Wong(Chinese University of Hong Kong), Raymond Wai Ming Lung(Chinese University of Hong Kong), Pik-Shan Li(Chinese University of Hong Kong), Alissa M. Wong(Chinese University of Hong Kong), Ka‐Fai To(Chinese University of Hong Kong), Ngai Na Co(Chinese University of Hong Kong), Tingting Sun(Northwest University), Paul B.S. Lai(Chinese University of Hong Kong), Ting‐Fung Chan(Chinese University of Hong Kong), Arthur K. Ching(Chinese University of Hong Kong), Jing‐Woei Li, Joanna H.M. Tong(Chinese University of Hong Kong), Anthony W.H. Chan(Chinese University of Hong Kong), Mian He(Qingdao Agricultural University), Henry Lik‐Yuen Chan(Radiant Research (United States))
Cited by 277
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
|Proceedings of the National Academy of Sciences|2015|818